Higher oxidative stress linked to metabolic syndrome

December 22, 2016

(HealthDay)—Oxidized low-density lipoprotein (ox-LDL) as a proxy for oxidative stress is associated with metabolic syndrome (MetS) and its components, according to a study published online Dec. 19 in Diabetes.

Yamilee Hurtado-Roca, M.D., from the Centro Nacional de Investigaciones Cardiovasculares Carlos III in Madrid, and colleagues examined the correlation between and MetS using data from 3,987 subjects without diabetes in the Progression of Early Subclinical Atherosclerosis study.

The researchers found that after adjustment for age, sex, smoking, LDL cholesterol, , waist circumference, and homeostatic model assessment of (HOMA-IR), the odds ratios for MetS for the second, third, and fourth quartiles of ox-LDL versus the first quartile were 0.84 (95 percent confidence interval, 0.52 to 1.36), 1.47 (95 percent confidence interval, 0.95 to 2.32), and 2.57 (95 percent confidence interval, 1.66 to 4.04) (P < 0.001 for trend). For all MetS components except glucose concentration, results showed the same trend. Overall, 13.9 percent of the association between waist circumference and triglycerides was mediated by ox-LDL, as was 1 to 3 percent of the association between and high-density lipoprotein cholesterol, blood pressure, and insulin resistance. The correlation between ox-LDL and MetS components was not mediated by HOMA-IR.

"Ox-LDL may reflect core mechanisms through which MetS components develop and progress in parallel with insulin resistance and could be a clinically relevant predictor of MetS development," the authors write.

Explore further: Evolocumab safe, effective for those with dysglycemia, MetS

More information: Full Text (subscription or payment may be required)

Related Stories

Evolocumab safe, effective for those with dysglycemia, MetS

September 16, 2016
(HealthDay)—For patients with or without dysglycemia or metabolic syndrome (MetS), evolocumab is safe and efficacious for reducing low-density lipoprotein cholesterol at 52 weeks, according to research published online ...

Neck circumference not tied to subclinical atherosclerosis

March 27, 2014
(HealthDay)—Neck circumference (NC) is not associated with either coronary or carotid subclinical atherosclerosis, according to a study published online March 19 in Clinical Cardiology.

Socioeconomic status in children tied to MetS in adulthood

October 28, 2016
(HealthDay)—Family socioeconomic status (SES) in childhood is associated with the risk for metabolic syndrome (MetS) and glucose abnormalities in adulthood, according to a study published online Oct. 18 in Diabetes Care.

Chemo ups metabolic syndrome risk in early-stage breast cancer

June 9, 2016
(HealthDay)—For patients with early-stage breast cancer with no preexisting metabolic syndrome (MetS), chemotherapy is associated with increased risk of MetS, according to a study published online May 24 in Cancer.

Metabolic syndrome linked to arterial stiffness in CKD

June 4, 2012
(HealthDay) -- For patients with chronic kidney disease (CKD), those with metabolic syndrome (MetS) have increased arterial stiffness but no increase in endothelial dysfunction, compared to those without MetS, according to ...

Metabolic syndrome tied to risk of mild cognitive impairment

March 2, 2016
(HealthDay)—The incidence of mild cognitive impairment (MCI) and MCI progression to dementia is increased in association with metabolic syndrome (MetS), according to a study published online Feb. 29 in JAMA Neurology.

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.